Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 708 (ZNF708) is a member of the zinc finger family of transcription factors. It contains classical C2H2-type zinc finger domains that enable it to bind DNA and regulate transcription, probably through interaction with RNA polymerase II-specific cis-regulatory regions[2][4]. The zinc finger protein family is the most abundant transcription factor class in eukaryotes, playing roles in genome stability, DNA damage repair, and cell proliferation[1]. ZNF708 is predicted to act in the regulation of DNA-templated transcription and is expressed in many tissues[2][3]. While some zinc finger proteins are established as therapeutic targets due to their roles in disease, ZNF708 itself is not yet a characterized target for drug development, nor are there established drugs or mechanisms of action involving this protein[2][4]. Diseases associated with ZNF708 include certain ovarian and testicular cancers, but its direct role in these diseases remains unclear[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 708 (ZNF708).